Indirect Hyperbilirubinemia

2

Review clinical trials related to Indirect Hyperbilirubinemia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Efficacy of Bifidobacterium Animalis Subsp. Lactis in the Treatment of Indirect Hyperbilirubinemia in Term Neonates

This study aims to evaluate the effectiveness of adjunctive oral Bifidobacterium animalis subsp. lactis in term neonates with indirect hyperbilirubinemia receiving phototherapy. The study will compare the effects of adjunctive probiotics plus standard phototherapy with standard phototherapy alone on the duration of phototherapy, length of hospital stay, serum total bilirubin reduction, phototherapy-related adverse events, and hospital readmission after discharge.

Participants needed: 90
Trial details
Age: Up to 28Biological sex: AllType: InterventionalSponsor: Can Tho University of Medicine and PharmacyUpdated: Aug 19, 2026Locations: 1
Eligibility criteria

Age from 0-28 days. [+4]

Direct hyperbilirubinemia (direct bilirubin >2.0 mg/dL and >20% of total serum b... [+5]

Status: Recruiting

COMPARISON OF ZINC AND PROBIOTICS ON NEONATES WITH INDIRECT HYPERBILIRUBINEMIA UNDERGOING PHOTOTHERAPY

Study will evaluate effects of oral zinc and probiotics supplementation in neonates who have indirect hyperbilirubinemia and are receiving phototherapy. Aim is to compare efficacy of these two drugs in clearing bilirubin and reducing duration of phototherapy. Neonates will be randomly assigned to receive either drug alongside phototherapy.

Participants needed: 110
Trial details
Phase: Phase 2Age: 0-28Biological sex: AllType: InterventionalSponsor: Quaid-e-Azam Medical CollegeUpdated: Aug 5, 2025Locations: 1
Eligibility criteria

1. Term or Near term neonates 2. Age <7 days at enrollment 3. Bilirubin levels w...

1. Positive sepsis screen or clinical signs of infection 2. Direct hyperbilirubi...